Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets

Molecules. 2022 Oct 4;27(19):6572. doi: 10.3390/molecules27196572.

Abstract

Currently, both acute kidney injury (AKI) and chronic kidney disease (CKD) are considered to be the leading public health problems with gradually increasing incidence rates around the world. Rhein is a monomeric component of anthraquinone isolated from rhubarb, a traditional Chinese medicine. It has anti-inflammation, anti-oxidation, anti-apoptosis, anti-bacterial and other pharmacological activities, as well as a renal protective effects. Rhein exerts its nephroprotective effects mainly through decreasing hypoglycemic and hypolipidemic, playing anti-inflammatory, antioxidant and anti-fibrotic effects and regulating drug-transporters. However, the latest studies show that rhein also has potential kidney toxicity in case of large dosages and long use times. The present review highlights rhein's molecular targets and its different effects on the kidney based on the available literature and clarifies that rhein regulates the function of the kidney in a positive and negative way. It will be helpful to conduct further studies on how to make full use of rhein in the kidney and to avoid kidney damage so as to make it an effective kidney protection drug.

Keywords: kidney protection; molecular targets; nephrotoxicity; rhein; traditional Chinese medicine.

Publication types

  • Review

MeSH terms

  • Anthraquinones / pharmacology
  • Anthraquinones / therapeutic use
  • Antioxidants* / pharmacology
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Kidney
  • Renal Insufficiency, Chronic*

Substances

  • Anthraquinones
  • Antioxidants
  • Hypoglycemic Agents
  • rhein